| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 372.98 mm | 372.98 mm | 372.98 mm | 372.98 mm | 372.98 mm | 372.98 mm |
| Cash burn (monthly) | 32.90 mm | (no burn) | 32.71 mm | 25.06 mm | (no burn) | 7.50 mm |
| Cash used (since last report) | 92.12 mm | n/a | 91.57 mm | 70.15 mm | n/a | 20.99 mm |
| Cash remaining | 280.87 mm | n/a | 281.41 mm | 302.83 mm | n/a | 351.99 mm |
| Runway (months of cash) | 8.5 | n/a | 8.6 | 12.1 | n/a | 46.9 |
| 13F holders | Current |
|---|---|
| Total holders | 102 |
| Opened positions | 46 |
| Closed positions | 83 |
| Increased positions | 30 |
| Reduced positions | 17 |
| 13F shares | Current |
|---|---|
| Total value | 1.30 tn |
| Total shares | 56.02 mm |
| Total puts | 275.20 k |
| Total calls | 186.70 k |
| Total put/call ratio | 1.5 |
| Largest owners | Shares | Value |
|---|---|---|
| T. Rowe Price | 10.92 mm | $445.95 mm |
| Ra Capital Management | 5.40 mm | $220.61 bn |
| Cowen Financial Products | 5.19 mm | $115.13 mm |
| BMY Bristol-Myers Squibb | 5.08 mm | $31.26 mm |
| JHG Janus Henderson | 3.66 mm | $149.49 bn |
| Adage Capital Partners GP, L.L.C. | 3.40 mm | $138.77 bn |
| STT State Street | 3.32 mm | $135.62 bn |
| LLY Eli Lilly and | 2.32 mm | $55.13 mm |
| Casdin Capital | 2.08 mm | $85.17 bn |
| Boxer Capital | 1.73 mm | $70.56 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Dec 24 | Teresa McCarthy | Common Stock | Sell | Dispose S | No | Yes | 32.66 | 11,151 | 364.19 k | 82,867 |
| 18 Dec 24 | Boyce Sarah | Common Stock | Sell | Dispose S | No | Yes | 32.66 | 31,855 | 1.04 mm | 265,308 |
| 18 Dec 24 | MacLean Michael F | Common Stock | Sell | Dispose S | No | Yes | 32.66 | 11,151 | 364.19 k | 82,942 |
| 18 Dec 24 | W. Michael Flanagan | Common Stock | Sell | Dispose S | No | Yes | 32.66 | 12,742 | 416.15 k | 72,647 |
| 16 Dec 24 | Teresa McCarthy | Common Stock | Sell | Dispose S | No | Yes | 33.2642 | 25,000 | 831.61 k | 94,018 |
| 16 Dec 24 | Teresa McCarthy | Common Stock | Option exercise | Acquire M | No | Yes | 14.22 | 25,000 | 355.50 k | 119,018 |
| 16 Dec 24 | Teresa McCarthy | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 14.22 | 25,000 | 355.50 k | 57,500 |
